Brief: Bioxyne Posts A$8.1 Mln Q2 Revenue
27/01/2025 23:02
Jan 28 (Reuters) - Bioxyne Ltd BXN.AX :
* A$8.1 MILLION (NOT A$6.1 MILLION) Q2 REVENUE
Further company coverage: BXN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: Bioxyne Secures A$50M Exclusive German Supply Agreement With Adrex
Australia's Bioxyne rises to near 8-year high after company secures German supply deal
Australia's Bioxyne at two-week high on supply deal with Remidose LATAM
Brief: Bioxyne Expands LATAM Footprint First Supply Agreement Costa Rica
Australia's Bioxyne hits nearly 8-year high on cannabis firm deal